Recent News
On February 14, 2026, a regulatory filing reported Krilogy Financial LLC established an $880,000 position in Ulta Beauty. No other non‑earnings corporate or material operational announcements meeting the date filter were identified within the recent window.
Technical Analysis
Directional Indicators (ADX / DI+ / DI-): ADX at 42.05 signals a very strong underlying trend. DI- at 41.25 and increasing indicates the dominant directional force remains bearish; DI+ shows a dip‑and‑reversal but sits at 12.79, so buying attempts prove insufficient relative to downside pressure. The strength of ADX combined with rising DI- biases the near‑term price path lower relative to current valuation levels.
MACD: MACD reads -36.51, declining and below its signal line (-30.75). Negative, falling MACD and the MACD line below the signal line confirm bearish momentum and reduce the probability that short-term rallies will sustain without a material change in momentum.
MRO (Momentum/Regression Oscillator): MRO at -15.88 indicates the market price sits below the internal target, implying mean‑reversion upside exists. The MRO trend is decreasing, however, which means that gap to that target widened recently—so a rebound remains possible but not immediate or confirmed by other momentum indicators.
RSI: RSI at 42.79 and decreasing shows weakening buying pressure; the oscillator sits above oversold thresholds but trending lower, permitting additional downside before typical technical oversold-triggered bounces occur.
Price Versus Averages and Bands: The last close of $510.09 sits below the 20‑day average ($538.37), below the 200‑day average ($559.21) and well under the 50‑day average ($634.83). The 12‑day EMA and 20‑day averages are declining. Price sits modestly above the 1x lower Bollinger band ($489.60), which can act as a nearby support zone for intraday mean reversion but does not negate the larger downtrend signaled by moving averages and ADX.
Ichimoku Context: Tenkan at $578.32 and Kijun at $600.92 both lie above the current price; Senkou A ($669.96) and Senkou B ($618.07) form a cloud well above market price, reinforcing a bearish regime.
Fundamental Analysis
Earnings and Estimates: For the period ending January 31, 2026 (report dated March 12, 2026), reported EPS equaled $8.01 versus an estimate of $8.04, a miss of $0.03 or -0.37%. Forward EPS stands at $7.8803 with a forward P/E of 76.64.
Growth Metrics: Reported earnings growth reads 55.84% (expressed as the supplied growth value), while year‑over‑year earnings growth shows -13.55% and quarter‑over‑quarter earnings growth shows -604.26% by the supplied metrics. Reported revenue growth shows 0.00% with revenue growth YoY and QoQ at -100.00% per the supplied values. These mixed values indicate divergence between headline growth figures and the period comparisons embedded in the reported metrics.
Profitability & Cash Flow: Cash flow margin and cash flow to earnings both register at 0.00% in the supplied figures. Invested capital totals $2,369,735,000. Cost of debt sits at 0.129%.
Valuation: Trailing P/E at 80.38 and forward P/E at 76.64 sit well above the industry peer mean for P/E (18.57) and above the stated industry peer high for trailing P/E (68.18). The PEG ratio at 1.4396 lies above the industry peer mean for PEG (0.1573). WMDST values the stock as over‑valued, driven by premium multiples relative to the industry peer mean and peer high while growth and cash‑conversion metrics display internal inconsistency.
MOST-RECENT QUARTERLY REPORT
| REPORT PERIOD ENDING: | 2026-01-31 |
| REPORT DATE: | 2026-03-12 |
| NEXT REPORT DATE: | 2026-06-11 |
| CASH FLOW | Begin Period Cash Flow | — |
| Operating Cash Flow | — | |
| Capital Expenditures | — | |
| Change In Working Capital | — | |
| Dividends Paid | — | |
| Cash Flow Delta | — | |
| End Period Cash Flow | — | |
| INCOME STATEMENT | REVENUE | |
| Total Revenue | — | |
| Forward Revenue | — | |
| COSTS | ||
| Cost Of Revenue | — | |
| Depreciation | — | |
| Depreciation and Amortization | — | |
| Research and Development | — | |
| Total Operating Expenses | — | |
| PROFITABILITY | ||
| Gross Profit | — | |
| EBITDA | — | |
| EBIT | — | |
| Operating Income | — | |
| Interest Income | — | |
| Interest Expense | — | |
| Net Interest Income | — | |
| Income Before Tax | — | |
| Tax Provision | — | |
| Tax Rate | — | |
| Net Income | — | |
| Net Income From Continuing Operations | — | |
| EARNINGS | ||
| EPS Estimate | $ 8.04 | |
| EPS Actual | $ 8.01 | |
| EPS Difference | $ -0.03 | |
| EPS Surprise | -0.373 % | |
| Forward EPS | $ 7.88 | |
| BALANCE SHEET | ASSETS | |
| Total Assets | — | |
| Intangible Assets | — | |
| Net Tangible Assets | — | |
| Total Current Assets | — | |
| Cash and Short-Term Investments | — | |
| Cash | — | |
| Net Receivables | — | |
| Inventory | — | |
| Long-Term Investments | — | |
| LIABILITIES | ||
| Accounts Payable | — | |
| Short-Term Debt | — | |
| Total Current Liabilities | — | |
| Net Debt | — | |
| Total Debt | — | |
| Total Liabilities | — | |
| EQUITY | ||
| Total Equity | — | |
| Retained Earnings | — | |
| VALUATION & PER-SHARE METRICS | EQUITY & PER-SHARE METRICS | |
| Book Value Per-Share | — | |
| Shares Outstanding | — | |
| Revenue Per-Share | — | |
| VALUATION | Market Capitalization | — |
| Enterprise Value | — | |
| Enterprise Multiple | — | |
| Enterprise Multiple QoQ | — | |
| Enterprise Multiple YoY | — | |
| Enterprise Multiple IPRWA | — | |
| EV/R | — | |
| CAPITAL STRUCTURE | ||
| Asset To Equity | — | |
| Asset To Liability | — | |
| Debt To Capital | — | |
| Debt To Assets | — | |
| Debt To Assets QoQ | — | |
| Debt To Assets YoY | — | |
| Debt To Assets IPRWA | — | |
| Debt To Equity | — | |
| Debt To Equity QoQ | — | |
| Debt To Equity YoY | — | |
| Debt To Equity IPRWA | — | |
| PRICE-BASED VALUATION | ||
| Price To Book (P/B) | — | |
| Price To Book QoQ | — | |
| Price To Book YoY | — | |
| Price To Book IPRWA | — | |
| Price To Earnings (P/E) | 80.384 | |
| Price To Earnings QoQ | -20.978 % | |
| Price To Earnings YoY | 78.201 % | |
| Price To Earnings IPRWA | ULTA: 80.384 high: 68.175 mean: 18.568 median: 10.951 low: -2.537 |
|
| PE/G Ratio | 1.44 | |
| Price To Sales (P/S) | — | |
| Price To Sales QoQ | — | |
| Price To Sales YoY | — | |
| Price To Sales IPRWA | — | |
| FORWARD MULTIPLES | ||
| Forward P/E | 76.64 | |
| Forward PE/G | 1.373 | |
| Forward P/S | — | |
| EFFICIENCY | OPERATIONAL | |
| Operating Leverage | — | |
| ASSET & SALES | ||
| Asset Turnover Ratio | — | |
| Asset Turnover Ratio QoQ | — | |
| Asset Turnover Ratio YoY | — | |
| Asset Turnover Ratio IPRWA | — | |
| Receivables Turnover | — | |
| Receivables Turnover Ratio QoQ | — | |
| Receivables Turnover Ratio YoY | — | |
| Receivables Turnover Ratio IPRWA | — | |
| Inventory Turnover | — | |
| Inventory Turnover Ratio QoQ | — | |
| Inventory Turnover Ratio YoY | — | |
| Inventory Turnover Ratio IPRWA | — | |
| Days Sales Outstanding (DSO) | — | |
| CASH CYCLE | ||
| Cash Conversion Cycle Days (CCC) | — | |
| Cash Conversion Cycle Days QoQ | — | |
| Cash Conversion Cycle Days YoY | — | |
| Cash Conversion Cycle Days IPRWA | — | |
| CAPITAL DEPLOYMENT | ||
| Cash Conversion Ratio | — | |
| CapEx To Revenue | — | |
| CapEx To Depreciation | — | |
| CAPITAL, LIQUIDITY & COVERAGE | CAPITAL STRUCTURE | |
| Total Capital | — | |
| Net Invested Capital | — | |
| Invested Capital | $ 2.4 B | |
| Net Tangible Assets | — | |
| Net Working Capital | — | |
| LIQUIDITY | ||
| Cash Ratio | — | |
| Current Ratio | — | |
| Current Ratio QoQ | — | |
| Current Ratio YoY | — | |
| Current Ratio IPRWA | — | |
| Quick Ratio | — | |
| Quick Ratio QoQ | — | |
| Quick Ratio YoY | — | |
| Quick Ratio IPRWA | — | |
| COVERAGE & LEVERAGE | ||
| Debt To EBITDA | — | |
| Cost Of Debt | 0.129 % | |
| Interest Coverage Ratio | — | |
| Interest Coverage Ratio QoQ | — | |
| Interest Coverage Ratio YoY | — | |
| Interest Coverage Ratio IPRWA | — | |
| Operating Cash Flow Ratio | — | |
| TIMING / LIQUIDITY | ||
| Days Payables Outstanding (DPO) | — | |
| DIVIDENDS | ||
| Dividend Coverage Ratio | — | |
| Dividend Payout Ratio | — | |
| Dividend Rate | — | |
| Dividend Yield | — | |
| PERFORMANCE | GROWTH | |
| Asset Growth Rate | — | |
| Revenue Growth | 0.0 % | |
| Revenue Growth QoQ | -100.0 % | |
| Revenue Growth YoY | -100.0 % | |
| Revenue Growth IPRWA | high: 24.194 % median: 24.194 % mean: 19.326 % ULTA: 0.0 % low: -20.068 % |
|
| Earnings Growth | 55.837 % | |
| Earnings Growth QoQ | -604.263 % | |
| Earnings Growth YoY | -13.553 % | |
| Earnings Growth IPRWA | high: 485.714 % mean: 296.195 % ULTA: 55.837 % median: -17.969 % low: -300.0 % |
|
| MARGINS | ||
| Gross Margin | — | |
| Gross Margin QoQ | — | |
| Gross Margin YoY | — | |
| Gross Margin IPRWA | — | |
| EBIT Margin | — | |
| EBIT Margin QoQ | — | |
| EBIT Margin YoY | — | |
| EBIT Margin IPRWA | — | |
| Return On Sales (ROS) | — | |
| Return On Sales QoQ | — | |
| Return On Sales YoY | — | |
| Return On Sales IPRWA | — | |
| CASH FLOW | ||
| Free Cash Flow (FCF) | — | |
| Free Cash Flow Yield | — | |
| Free Cash Flow Yield QoQ | — | |
| Free Cash Flow Yield YoY | — | |
| Free Cash Flow Yield IPRWA | — | |
| Free Cash Growth | — | |
| Free Cash Growth QoQ | — | |
| Free Cash Growth YoY | — | |
| Free Cash Growth IPRWA | — | |
| Free Cash To Net Income | — | |
| Cash Flow Margin | 0.0 % | |
| Cash Flow To Earnings | 0.0 | |
| VALUE & RETURNS | ||
| Economic Value Added | — | |
| Return On Assets (ROA) | — | |
| Return On Assets QoQ | — | |
| Return On Assets YoY | — | |
| Return On Assets IPRWA | — | |
| Return On Capital Employed (ROCE) | — | |
| Return On Equity (ROE) | — | |
| Return On Equity QoQ | — | |
| Return On Equity YoY | — | |
| Return On Equity IPRWA | — | |
| DuPont ROE | — | |
| Return On Invested Capital (ROIC) | — | |
| Return On Invested Capital QoQ | — | |
| Return On Invested Capital YoY | — | |
| Return On Invested Capital IPRWA | — | |